AN2 Therapeutics, Inc.

Q4 2024 13F Holders

Symbol
ANTX
CUSIP
037326105
Type
Equity
Class
COM
Num filings
39
Total reported value, excl. options
$20.1 M
Manager Report Date Value ($000) Shares Option Type